Drugs like Zepbound and Wegovy are intended for people who are overweight. Some patients are using them after bariatric surgery to keep pounds from creeping back. Others may just want to lose a few ...

A public health expert explains how GLP-1 drugs have changed the way healthcare providers understand and treat obesity.

A new study on the impact of excess weight around the midsection — aka abdominal obesity — raises questions about causes, harms, and fixes. A large new study found that about 1 in 5 adults worldwide ...

Is obesity a disease or a risk factor for disease? In medical circles – and outside of them – the question is contentious, with supporters on either side. In a newly published report, the Global ...

Calculating your ideal body weight (IBW) can help you gain some insight into your possible risk for weight-related health conditions. However, this tool doesn’t always provide an accurate assessment.

New guidance from a team of health experts around the world proposes expanding the definition of obesity beyond the popular body mass index (BMI) measure. The new guidance comes from the Commission on ...

People with severe obesity have a drastically increased risk of suffering a severe illness or even death from infections, according to a new analysis of health data from more than 540,000 patients in ...

Obesity is a common risk factor for various long-term conditions (LTCs), according to a February study published in Nature Communications.

Demand for GLP-1 drugs continues to climb, boosted by a major price drop and the FDA’s approval of an oral Wegovy pill that ...

Individuals with obesity may experience a lower incidence of acute complications following TBI, supporting the "obesity paradox." ...